Depdc5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Depdc5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
DEPDC5 encodes a core component of the GATOR1 complex (GAP Activity Toward Rags 1), which is a critical negative regulator of the mTORC1 (mechanistic Target of Rapamycin Complex 1) signaling pathway. DEPDC5 is the scaffold protein of the GATOR1 complex, which also includes NPRL3 and NPRL2. This complex functions as a GAP (GTPase-activating protein) for Rag GTPases, thereby inhibiting mTORC1 when amino acids are limiting. In the nervous system, DEPDC5 plays important roles in neuronal development, synaptic plasticity, and is implicated in various neurological disorders. [@kim2021]
Gene Structure
The DEPDC5 gene consists of:
42 exons spanning approximately 120 kb
Multiple transcript variants
Alternative splicing produces isoforms
Protein Structure
DEPDC5 is a 1723 amino acid protein containing:
N-terminal DEP domain (disheveled, EGL-10, pleckstrin)
Central proline-rich region
Multiple protein interaction domains
Coiled-coil regions
Molecular Function
GATOR1 Complex
DEPDC5 is the scaffold:
Forms heterodimeric complexes with NPRL2 and NPRL3
Provides substrate specificity for Rag GTPases
Couples amino acid sensing to mTORC1 regulation
Rag GTPase GAP Activity
Accelerates GTP hydrolysis on RagA/B
Prevents RagC/D activation
Inhibits mTORC1 recruitment to lysosomes
Amino Acid Sensing
Part of amino acid-sensing pathway
Responds to cytosolic amino acid levels
Integrates with lysosomal amino acid sensing
Expression Pattern
DEPDC5 is widely expressed:
Brain: High expression in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum
[Neurons](/entities/neurons): Dendrites and synapses
Glia: [Astrocytes](/entities/astrocytes) and oligodendrocytes
Peripheral tissues: Ubiquitous expression
Role in Neurodegeneration
Epilepsy
DEPDC5 mutations cause autosomal dominant focal epilepsy
Focal cortical dysplasia type IIA linked to DEPDC5
Hemimegalencephaly associated with mutations
[mTOR](/entities/mtor) hyperactivation in affected neurons
Alzheimer's Disease
[mTOR](/mechanisms/mtor-signaling-pathway) signaling dysregulated in AD
GATOR1 components affected in AD brains
[Autophagy](/entities/autophagy) impairment linked to DEPDC5
Therapeutic targeting explored
Parkinson's Disease
mTOR pathway alterations in PD
DEPDC5 role in [alpha-synuclein](/mechanisms/alpha-synuclein) toxicity
Autophagy-lysosomal pathway involvement
Tuberous Sclerosis Complex
Related to mTORC1 overactivation
Shared signaling pathway with TSC1/TSC2
Rapamycin responsive
Intellectual Disability
DEPDC5 mutations cause non-syndromic ID
Developmental brain malformations
Autism spectrum disorders
Therapeutic Implications
Drug Targets
mTOR inhibitors: Rapamycin, everolimus
DEPDC5 activators: Under investigation
GATOR1 complex modulators
Research Directions
Understanding mTOR regulation
Developing brain-penetrant inhibitors
Gene therapy approaches
Animal Models
Depdc5 knockout mice: Embryonic lethal
Conditional knockouts: Neuron-specific phenotypes
Zebrafish models: Brain malformations
Background
The study of Depdc5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[Bar-Peled L, et al, A tumor suppressor complex with GAP activity for the Rag GTPases that activate mTORC1 (2013)](https://pubmed.ncbi.nlm.nih.gov/23747061/)
[Sancak Y, et al, Ragulator-Rag complex targets mTORC1 to the lysosomal surface (2013)](https://pubmed.ncbi.nlm.nih.gov/23629764/)
[Baybis M, et al, DEPDC5 mutations in focal epilepsy (2014)](https://pubmed.ncbi.nlm.nih.gov/24634157/)
[Ribierre T, et al, DEPDC5 and mTOR in epilepsy (2018)](https://pubmed.ncbi.nlm.nih.gov/29878086/)
[Marsan E, et al, DEPDC5 mutations in cortical dysplasia (2016)](https://pubmed.ncbi.nlm.nih.gov/27606331/)
[Duan M, et al, GATOR1 complex in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32394126/)
[Hughes J, et al, Autophagy regulation by DEPDC5 (2021)](https://pubmed.ncbi.nlm.nih.gov/33353489/)
[Kim YJ, et al, Epilepsy and mTOR signaling (2021)](https://pubmed.ncbi.nlm.nih.gov/34262445/)